| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $622K | +36.7% | -6.5% |
| Cost of Revenue | $335K | +26.4% | -2.3% |
| Gross Profit | $287K | +51.1% | -10.9% |
| R&D Expense | $679K | -30.0% | +10.9% |
| SG&A Expense | $2.3M | -17.3% | +1.2% |
| Operating Income | -$3.5M | +17.8% | -9.7% |
| Pre-tax Income | -$2.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $103.8M | -2.3% | +192.0% |
| Current Assets | $104.8M | -2.2% | +163.6% |
| Total Assets | $105.6M | -2.3% | +157.6% |
| Current Liabilities | $6.2M | -0.1% | -41.2% |
| Total Liabilities | $7.3M | -2.2% | -38.5% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.3M | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $80K | — | — |
| +23.4% |
| +12.7% |
| Income Tax | $0 | — | — |
| Net Income | -$2.4M | +23.4% | +12.7% |
| EPS (Basic) | -$0.12 | +25.0% | +52.0% |
| EPS (Diluted) | -$0.12 | +25.0% | +52.0% |
| $98.3M |
| -2.3% |
| +237.6% |